Vyzkoušet demo Otevřít účet
Obchodování
CFD
Binární opce
Krypto
Bankovnictví
B2B
Zprávy z trhu
O nás
Vyzkoušet demo Otevřít účet

Novartis to take over Endocyte in $2.1B cash deal

Note: This section contains information in English only.
Source: Dukascopy Bank SA
Novartis is set to buy the US cancer pharma company Endocyte in an all-cash deal valued at $2.1B, amid Swiss drugmaker's expansion plan of its radiopharmaceuticals business.
Back to articles

Actual Topics

18 Oct 2018

Fashion company Nine West files amended bankruptcy plan

The US apparel and footwear firm Nine West Holdings has filed an amended Chapter 11 plan that should cut the company's pre-bankruptcy debt obligations by over $1.0B.

18 Oct 2018

Tata Group seeks to acquire Jet Airways stake

Tata Group, India's business conglomerate, is in preliminary talks to acquire a majority stake in the Indian debt-laden Jet Airways according to the Times of India report seen on Wednesday.

18 Oct 2018

US EPA discusses emissions issue with Volvo

On Wednesday, the US Environmental Protection Agency stated it was in discussion with Volvo over the carmaker's catalytic converters issue that caused its vehicles to exceed the limits of nitrogen oxide emissions.